How to buy Organovo stock | $10.28

Organovo Holdings, Inc is a diagnostics & research business based in the US. Organovo shares (ONVO) are listed on the NASDAQ and all prices are listed in US Dollars. Organovo employs 6 staff and has a trailing 12-month revenue of around USD$1.5 million.

How to buy shares in Organovo

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Organovo. Find the stock by name or ticker symbol: ONVO. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Organovo reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$10.28, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Organovo, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Organovo. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Organovo share price

Use our graph to track the performance of ONVO stocks over time.

Organovo shares at a glance

• Key figures

Information last updated 2020-10-21.

Latest market close	USD$10.28
52-week range	USD$0.1933 - USD$13.6
50-day moving average	USD$7.7809
200-day moving average	USD$10.3752
Wall St. target price	USD$3
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.214

Buy Organovo shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Organovo stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Organovo Holdings, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Organovo price performance over time

Historical closes compared with the close of $10.28 from 2020-12-18

1 week (2021-01-08)	-19.56%
1 month (2020-12-16)	41.40%
3 months (2020-10-16)	6.42%
6 months (2020-07-16)	1,531.75%

1 year (2020-01-16)	2,135.75%
2 years (2019-01-16)	817.86%
3 years (2018-01-16)	655.88%
5 years (2016-01-15)	446.81%

Organovo financials

Revenue TTM	USD$1.5 million
Gross profit TTM	USD$-3,416,000
Return on assets TTM	-21.74%
Return on equity TTM	-49.75%
Profit margin	0%
Book value	$3.795
Market capitalisation	USD$55.2 million

TTM: trailing 12 months

Shorting Organovo shares

There are currently 145,381 Organovo shares held short by investors – that's known as Organovo's "short interest". This figure is 44.9% up from 100,329 last month.

There are a few different ways that this level of interest in shorting Organovo shares can be evaluated.

Organovo's "short interest ratio" (SIR)

Organovo's "short interest ratio" (SIR) is the quantity of Organovo shares currently shorted divided by the average quantity of Organovo shares traded daily (recently around 106897.79411765). Organovo's SIR currently stands at 1.36. In other words for every 100,000 Organovo shares traded daily on the market, roughly 1360 shares are currently held short.

However Organovo's short interest can also be evaluated against the total number of Organovo shares, or, against the total number of tradable Organovo shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Organovo's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Organovo shares in existence, roughly 20 shares are currently held short) or 0.0286% of the tradable shares (for every 100,000 tradable Organovo shares, roughly 29 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Organovo.

Find out more about how you can short Organovo stock.

Organovo share dividends

We're not expecting Organovo to pay a dividend over the next 12 months.

Have Organovo's shares ever split?

Organovo's shares were split on a 1:20 basis on 19 August 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Organovo shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Organovo shares which in turn could have impacted Organovo's share price.

Organovo share price volatility

Over the last 12 months, Organovo's shares have ranged in value from as little as $0.1933 up to $13.6. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Organovo's is 0.9459. This would suggest that Organovo's shares are less volatile than average (for this exchange).

Organovo overview

Organovo Holdings, Inc., a biotechnology company, develops bioprinted human tissues based on its 3D human tissue platform technology that emulate human biology and diseases. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases; and NovoTissues liver product using cells from a liver donor and cells from an umbilical cord donor. The company was founded in 2007 and is headquartered in Solana Beach, California.

Frequently asked questions

• What percentage of Organovo is owned by insiders or institutions?

  Currently 0.317% of Organovo shares are held by insiders and 38.104% by institutions.

• How many people work for Organovo?

  Latest data suggests 6 work at Organovo.

• When does the fiscal year end for Organovo?

  Organovo's fiscal year ends in March.

• Where is Organovo based?

  Organovo's address is: 440 Stevens Avenue, Solana Beach, CA, United States, 92075

• What is Organovo's ISIN number?

  Organovo's international securities identification number is: US62620A1046

• What is Organovo's CUSIP number?

  Organovo's Committee on Uniform Securities Identification Procedures number is: 62620A104